Trial intelligence / Profile preview

MATE: Metformin and Aging Trial

NCT03451006Phase 2Terminated

Sponsor
Mayo Clinic
Start
May 2018
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of liquid metformin (Aspargo Labs) in frailty syndrome, sponsored by Mayo Clinic. Started May 2018; status: terminated.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

frailty syndrome

Beyond the preview

Go deeper on NCT03451006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03451006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call